Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1632 1633 1637 1651
This examiner grants 60% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17779505 | NOVEL AAV3B VARIANTS THAT TARGET HUMAN HEPATOCYTES IN THE LIVER OF HUMANIZED MICE | Final Rejection | University of Massachusetts |
| 18019931 | PLATFORM VECTOR FOR MODULAR AND SIMPLIFIED INSERTION OF TRANSGENES INTO ALPHAHERPESVIRINAE | Final Rejection | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e. V. |
| 18026482 | CELL-SUPPORTING BODY, MANUFACTURING METHOD THEREFOR, CELL CULTURING METHOD, AND CELL STRUCTURE | Non-Final OA | Konica Minolta, Inc. |
| 18547840 | Opsins as Chemosensory Receptors and Related Methods | Non-Final OA | The Regents of the University of California |
| 18726384 | Systems and Methods Incorporating Modified T-Cells | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18727951 | METHOD FOR EVALUATING CARDIOMYOCYTES USING RAMAN SCATTERING | Non-Final OA | National Institute of Advanced Industrial Science and Technology |
| 17767822 | STEM CELL-DERIVED MATURE CARDIOMYOCYTES AND CARDIOVASCULAR DISEASE MODEL USING SAME | Final Rejection | KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION |
| 17614673 | DRUG TARGET OF IDIOPATHIC PULMONARY FIBROSIS | Non-Final OA | National Institute of Biological Sciences, Beijing |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy